NEW YORK, Oct. 15 – NetGenics has completed the second phase of its DiscoveryCenter database build-out for Schering and its US subsidiary Berlex Laboratories, the company said on Monday.

The three-part implementation, scheduled to close around February 2002, provides a single point of access to curated and annotated gene-sequence and -expression data for Schering’s R&D scientists, according to NetGenics CEO Manual Glynias. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.